Inside MassBioDrive
Participating in the MassBioDrive program offers biotech founders a unique opportunity to accelerate their growth and success. By participating in MassBioDrive, founders can leverage these advantages to drive their innovation, overcome barriers, and make significant strides toward bringing life-changing treatments to patients worldwide.
Learn more about the application
During each hybrid 8-week program, the MassBioDrive cohorts are supported with:
Access to Expertise
Startups connected with industry experts, seasoned entrepreneurs, and experienced mentors who provide invaluable guidance on business development, clinical strategy, regulatory pathways, and commercialization.
Networking Opportunities
Unparalleled networking with potential partners, investors, and key stakeholders in the biotech ecosystem to unlock collaborations, funding, and strategic alliances.
Resource Access
Receive an equity-free stipend from Bristol Myers Squibb, along with access to and/or resources from MassBioDrive partners, including Evaluate and Google Startup.
Visibility Opportunities
Cohorts receive additional visibility with top-tier funders and strategic partners through pitch events, showcases, and MassBio social channels.
Community Support
Part of a vibrant and supportive community of like-minded innovators, providing a collaborative environment that fosters knowledge sharing, peer learning, and mutual support.
Accelerated Support
With a focus on intensive learning, startups achieve critical business fundamental milestones faster.
Get Involved
MassBioDrive invites industry professionals and students to support life science startups through mentoring, volunteering as analysts, or providing resources like consulting and technology access.
Meet our Partners
Our partners are experts in areas like drug development, business, legal strategy, and fundraising and provide critical resources, funding, and guidance to help startups thrive in the life sciences industry.
Our MassBioDrive alumni span a wide range of therapeutic areas, including oncology, neurodegenerative diseases, and regenerative medicine. The companies hail from diverse locations across the United States and beyond, showcasing the program’s broad reach and impact.